Fully updated third annual industry insider report detailing markets and emerging diagnostics in neurology and psychiatry.
Nearly 2 billion people worldwide and 100 million people in the US are affected by a brain or nervous system disorder including addiction, Alzheimer’s, depression, anxiety, schizophrenia, attention disorders, epilepsy, Parkinson’s disease, sensory disorders, and sleep disorders. Diagnosis of these disorders is rapidly changing as new tools are developed for more objective and personalized assessment and treatment.
In addition to the massive unmet markets, long term growth in neurodiagnostics is being driven by 1) technology advances and equipment upgrades in neuroimaging, 2) new biomarkers and imaging protocols for early diagnosis and disease monitoring, and 3) increased use of imaging and informatics in drug and device development.
The Neurodiagnostics Report 2012: Brain Imaging, Biomarkers and NeuroInform...
Or leave us a message and we'll call you back!
Receive bi-weekly email alerts for new market research.